J. Monen
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antimicrobial Resistance in Staphylococcus 10
- Clostridium difficile and Clostridium perfringens research 3
-
- Pneumonia and Respiratory Infections 4
- Pneumocystis jirovecii pneumonia detection and treatment 1
- Co-authors
- Hajo Grundmann (10 shared papers)Edine Tiemersma (7 shared papers)Marlieke E.A. de Kraker (6 shared papers)N. van de Sande-Bruinsma (6 shared papers)Vincent Jarlier (4 shared papers)Ole Eske Heuer (4 shared papers)S L A M Bronzwaer (3 shared papers)John E. Degener (2 shared papers)
- Journals
- Eurosurveillance (5 papers)Clinical Microbiology and Infection (3 papers)PLoS ONE (3 papers)Journal of Antimicrobial Chemotherapy (2 papers)Emerging infectious diseases (2 papers)
- Partner nations
- NetherlandsFranceMalta
In The Last Decade
J. Monen
19 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 115
- Applied Microbiology and Biotechnology 427
- Molecular Medicine 359
- Clinical Biochemistry 420
- Infectious Diseases 698
- Microbiology 94
Countries citing papers authored by J. Monen
This map shows the geographic impact of J. Monen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Monen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Monen more than expected).
Fields of papers citing papers by J. Monen
This network shows the impact of papers produced by J. Monen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Monen. The network helps show where J. Monen may publish in the future.
Co-authors
The 25 scholars most cited alongside J. Monen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 440 | |
| 2 | 2008 | 383 | |
| 3 | 2012 | 310 | |
| 4 | 2011 | 161 | |
| 5 | 2007 | 125 | |
| 6 | 2004 | 57 | |
| 7 | 2006 | 56 | |
| 8 | 2009 | 48 | |
| 9 | 2021 | 34 | |
| 10 | 2014 | 33 | |
| 11 | 1994 | 29 | |
| 12 | 2019 | 26 | |
| 13 | 2008 | 19 | |
| 14 | 2013 | 17 | |
| 15 | 2012 | 16 | |
| 16 | 2001 | 15 | |
| 17 | Literaturverzeichnis zum Beitrag "Fachtagung der AG Nosokomiale Infektionen am RKI zur Intensivierung der Umsetzung von Präventionsstrategien bei MRSA" | 2005 | 11 |
| 18 | 1998 | 6 | |
| 19 | 2011 | 1 |
About J. Monen
J. Monen is a scholar working on Infectious Diseases, Epidemiology, Molecular Medicine, Applied Microbiology and Biotechnology and Clinical Biochemistry, having authored 19 papers that have together received 1.8k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (10 papers), Antibiotic Resistance in Bacteria (6 papers), Antibiotic Use and Resistance (5 papers), Pneumonia and Respiratory Infections (4 papers), Clostridium difficile and Clostridium perfringens research (3 papers), Bacterial Identification and Susceptibility Testing (3 papers), Visual perception and processing mechanisms (2 papers) and Pneumocystis jirovecii pneumonia detection and treatment (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (427 citations), Molecular Medicine (359 citations), Clinical Biochemistry (420 citations), Infectious Diseases (698 citations) and Microbiology (94 citations). J. Monen has collaborated with scholars based in Netherlands, France and Malta. Frequent co-authors include Hajo Grundmann, Edine Tiemersma, Marlieke E.A. de Kraker, N. van de Sande-Bruinsma, Vincent Jarlier, Ole Eske Heuer, S L A M Bronzwaer, John E. Degener, Nienke Bruinsma and Didier Verloo. Their work appears in journals such as Eurosurveillance, Clinical Microbiology and Infection, PLoS ONE, Journal of Antimicrobial Chemotherapy and Emerging infectious diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.